WHO SMART Guidelines - HIV
0.3.0 - ci-build

WHO SMART Guidelines - HIV - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Library: HIV.IND.44 Logic (Experimental)

Official URL: http://smart.who.int/hiv/Library/HIVIND44Logic Version: 0.3.0
Draft as of 2024-10-30 Computable Name: HIVIND44Logic

Number and % of eligible people living with HIV on ART who initiated TB preventive treatment

Generated Narrative: Library HIVIND44Logic

Related Artifacts

Depends OnLibrary HICHIVCommon
Depends OnLibrary WComWHOCommon
Depends OnLibrary HEHIVElements
Depends OnLibrary HIEHIVIndicatorElements

Parameters

Measurement Periodin01Period
Patientout01Patient
Initial Populationout01boolean
Numeratorout01boolean
Denominatorout01boolean
Administrative Gender Stratifierout01Coding
Age Stratifierout01string
TPT Regimen Type Stratifierout0*CodeableConcept
Geographic Region Stratifierout01string
Stratificationout01string

Contents

text/cql

/**
 * Library: HIV.IND.44 Logic
 * Ref No: TBH.1
 * Short Name: TPT initiation
 *
 * Definition: Number and % of eligible people living with HIV on ART who initiated TB preventive treatment
 *
 * Numerator: Number of ART patients who initiated TPT during the reporting period
 * Numerator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the reporting period
 * Numerator Exclusions: 
 *
 * Denominator: Number of ART patients who are eligible for TPT during the reporting period
 * Denominator Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True at end of last reporting period AND "Eligible for TB preventive treatment"=True
 * Denominator Exclusions: 
 *
 * Disaggregations:
 *  • Gender (female, male, other*) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)** 
 *  • Type of TPT regimen 
 *  • Cities and other administrative regions of epidemiologic importance
 *
 * Disaggregation Elements: Gender | Age | TPT regimen type
 *
 * Numerator and Denominator Elements:
 * Eligible for TB preventive treatment 
 *  HIV status 
 *  On ART 
 *  TB preventive treatment (TPT) start date
 *
 * Reference: Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact. Geneva: World Health Organization; 2022
 * 
 * Data Concepts:
 * HIV.A.DE17: Age | Calculated age (number of years) of the client based on date of birth
 * HIV.A.DE18: Gender* | Gender of the client*
 * HIV.A.DE19: Female | Client identifies as female
 * HIV.A.DE20: Male | Client identifies as male
 * HIV.A.DE21: Transgender male | Client identifies as transgender male
 * HIV.A.DE22: Transgender female | Client identifies as transgender female
 * HIV.A.DE23: Other | Additional category
 * HIV.B.DE115: HIV status | HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.
 * HIV.B.DE116: HIV-positive | Client is HIV-positive
 * HIV.B.DE117: HIV-negative | Client is HIV-negative
 * HIV.B.DE118: Unknown | Client has unknown HIV status
 * HIV.D.DE38: On ART | Client is currently taking ART
 * HIV.D.DE954: TB preventive treatment (TPT) start date | The date on which the client began taking TPT
 * HIV.D.DE1017: Eligible for TB preventive treatment | Client is eligible for tuberculosis preventive treatment (TPT)
 * HIV.D.DE1028: TPT regimen type | Type of TPT regimen the client is currently on
 * HIV.D.DE1029: 3HP | The client's current TPT regimen is 3HP
 * HIV.D.DE1030: 1HP | The client's current TPT regimen is 1HP
 * HIV.D.DE1031: 6H | The client's current TPT regimen is 6H
 * HIV.D.DE1032: Six months of levofloxacin daily | The client's current TPT regimen is six months of levofloxacin daily
 * HIV.D.DE1033: Other TB preventive treatment (TPT) regimen | The client's current TPT regimen is another regimen than those listed above
 * HIV.H.DE47: On ART | Client is currently taking ART 
 *
 * Additional Context
 * - what it measures: This indicator measures the extent to which people on ART initiated treatment for latent TB infection.
 * - rationale: • TB preventive treatment (TPT) is a critical component of preventing TB-related morbidity and mortality among people living with HIV. | • In the wake of recent high-level global commitments and targets, this is a critical period to track the progress that countries have made in scaling up TPT coverage.
 * - method: For the numerator: Programme records (for example, ART registers) | For the denominator: Formula for determining the number of ART patients who are eligible for TPT during the reporting period | Number of people living with HIV on ART at end of last reporting period | minus | Number of notified HIV-positive TB patients in last reporting period | also minus, where possible | Number of people living with HIV who previously received TPT – actual, if available, or based on country estimate | also minus, where possible number/estimate of people living with HIV not eligible for TPT due to co-morbidities, including active hepatitis, chronic alcoholism and/or neuropathy
 * 
 * Suggested Scoring Method: proportion | http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm
 */

library HIVIND44Logic

// Included Libraries
using FHIR version '4.0.1'

include HIVCommon called HIC
include FHIRHelpers version '4.0.1'

include WHOCommon called WCom

include HIVElements called HE
include HIVIndicatorElements called HIE

// Indicator Definition
parameter "Measurement Period" Interval<Date> default Interval[@2023-01-01, @2023-01-30]

context Patient
/* Populations */

/*
 *Initial Population
 */

define "Initial Population":
  true

/**
 * Numerator
 * 
 * Definition: Number of ART patients who initiated TPT during the reporting period
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True AND "TB preventive treatment (TPT) start date" in the reporting period
 */

define "Numerator":
 HIE."Has HIV-positive Status" and HIE."On ART" and exists(HIE."TB preventive treatment TPT start date in measurement period")

/**
 * Denominator
 *
 * Definition: Number of ART patients who are eligible for TPT during the reporting period
 * Calculation: COUNT of clients with "HIV status"='HIV-positive' AND "On ART"=True at end of last reporting period AND "Eligible for TB preventive treatment"=True
 */

define "Denominator":
 HIE."Has HIV-positive Status" and HIE."On ART" and HIE."Eligible for TB preventive treatment"
    

/* end Populations */

/*
 * Disaggregations:
 *  • Gender (female, male, other*) 
 *  • Age (0–4, 5–9, 10–14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50+ years)** 
 *  • Type of TPT regimen 
 *  • Cities and other administrative regions of epidemiologic importance
 */

define "Administrative Gender Stratifier":
	HIE."By Administrative Gender Stratifier"

define "Age Stratifier":
  HIE."By Age Stratifier"

define "TPT Regimen Type Stratifier":
  HIE."TPT regimen type"

define "Geographic Region Stratifier":
  HIE."By Geographic Region Stratifier"

/*
 * Combined stratifiers
 */
define "Stratification":
  HIE."By Administrative Gender Stratifier".code 
    + ':' + HIE."By Age Stratifier"
    + ':' + Combine(HIE."TPT regimen type".coding.code)
	  + ':' + HIE."By Geographic Region Stratifier"

Content not shown - (application/elm+xml, size = 29Kb )